Rocket Pharmaceuticals, Inc. Interest and Other Income
Rocket Pharmaceuticals, Inc. (RCKT) reported Interest and Other Income of $347.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-10
- Rocket Pharmaceuticals, Inc. interest and other income for the quarter ending 2026-06-30 was $347.00K, a 28.16% decline year-over-year.
- Rocket Pharmaceuticals, Inc. interest and other income for the quarter ending 2026-03-31 was $161.00K, a 87.95% decline year-over-year.
- Rocket Pharmaceuticals, Inc. interest and other income for the quarter ending 2025-12-31 was $690.00K, a 57.33% decline year-over-year.
- Rocket Pharmaceuticals, Inc. interest and other income for the quarter ending 2025-09-30 was $709.00K, a 46.57% decline year-over-year.
- Rocket Pharmaceuticals, Inc. interest and other income for fiscal 2025 was $3.22M, a 61.07% decline from fiscal 2024.
- Rocket Pharmaceuticals, Inc. interest and other income for fiscal 2024 was $8.27M, a 56.34% increase from fiscal 2023.
- Rocket Pharmaceuticals, Inc. interest and other income for fiscal 2023 was $5.29M, a 35.97% increase from fiscal 2022.
- Rocket Pharmaceuticals, Inc. interest and other income for fiscal 2022 was $3.89M, a 26.76% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 3 month as first filed | Interest and Other Income 6 month | Interest and Other Income 6 month as first filed | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $347.00K 10-Q · filed 2026-08-10 | $508.00K 10-Q · filed 2026-08-10 | $1.20M derived: sum of 3 quarters · filed 2026-08-10 | $1.91M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $161.00K 10-Q · filed 2026-05-07 | $851.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.56M derived: sum of 3 quarters · filed 2026-05-07 | $2.04M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.40M derived: sum of 2 quarters · filed 2026-02-26 | $1.88M derived: sum of 3 quarters · filed 2026-08-10 | $3.22M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $709.00K 10-Q · filed 2025-11-06 | $1.19M derived: sum of 2 quarters · filed 2026-08-10 | $2.53M 10-Q · filed 2025-11-06 | $4.14M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $483.00K 10-Q · filed 2026-08-10 | $1.82M 10-Q · filed 2026-08-10 | $3.44M derived: sum of 3 quarters · filed 2026-08-10 | $4.76M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $1.34M 10-Q · filed 2026-05-07 | $2.95M derived: sum of 2 quarters · filed 2026-05-07 | $4.28M derived: sum of 3 quarters · filed 2026-05-07 | $6.57M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.94M derived: sum of 2 quarters · filed 2026-02-26 | $5.24M derived: sum of 3 quarters · filed 2026-02-26 | $8.27M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $1.33M 10-Q · filed 2025-11-06 | $3.62M derived: sum of 2 quarters · filed 2025-11-06 | $6.65M 10-Q · filed 2025-11-06 | $7.46M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $2.29M 10-Q · filed 2025-08-07 | $5.32M 10-Q · filed 2025-08-07 | $6.14M derived: sum of 3 quarters · filed 2025-08-07 | $7.86M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $3.03M 10-Q · filed 2025-05-08 | $3.84M derived: sum of 2 quarters · filed 2025-05-08 | $5.56M derived: sum of 3 quarters · filed 2025-05-08 | $6.41M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $814.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.53M derived: sum of 2 quarters · filed 2025-02-27 | $3.38M derived: sum of 3 quarters · filed 2025-02-27 | $5.29M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | $1.72M 10-Q · filed 2024-11-07 | $2.57M derived: sum of 2 quarters · filed 2024-11-07 | $4.47M 10-Q · filed 2024-11-07 | $5.72M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $846.00K 10-Q · filed 2024-08-06 | $2.75M 10-Q · filed 2024-08-06 | $4.00M derived: sum of 3 quarters · filed 2025-02-27 | $5.35M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $1.91M 10-Q · filed 2024-05-07 | $3.15M derived: sum of 2 quarters · filed 2025-02-27 | $4.51M derived: sum of 3 quarters · filed 2025-02-27 | $5.17M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.60M derived: sum of 2 quarters · filed 2025-02-27 | $3.27M derived: sum of 3 quarters · filed 2025-02-27 | $3.89M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $1.35M 10-Q · filed 2023-11-07 | $2.02M derived: sum of 2 quarters · filed 2023-11-07 | $2.64M 10-Q · filed 2023-11-07 | $3.50M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $669.00K 10-Q · filed 2023-08-09 | $1.29M 10-Q · filed 2023-08-09 | $2.14M derived: sum of 3 quarters · filed 2024-02-27 | $2.95M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $623.00K 10-Q · filed 2023-05-05 | $1.47M derived: sum of 2 quarters · filed 2024-02-27 | $2.28M derived: sum of 3 quarters · filed 2024-02-27 | $2.78M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $850.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.66M derived: sum of 2 quarters · filed 2024-02-27 | $2.16M derived: sum of 3 quarters · filed 2024-02-27 | $3.07M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $806.00K 10-Q · filed 2022-11-04 | $1.31M derived: sum of 2 quarters · filed 2022-11-04 | $2.22M 10-Q · filed 2022-11-04 | $2.46M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $501.00K 10-Q · filed 2022-08-09 | $1.41M 10-Q · filed 2022-08-09 | $1.65M derived: sum of 3 quarters · filed 2023-02-28 | $2.17M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $911.00K 10-Q · filed 2022-05-06 | $1.15M derived: sum of 2 quarters · filed 2023-02-28 | $1.67M derived: sum of 3 quarters · filed 2023-02-28 | $2.10M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $755.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.18M derived: sum of 3 quarters · filed 2023-02-28 | $2.15M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $518.00K 10-Q · filed 2021-11-05 | $947.00K derived: sum of 2 quarters · filed 2021-11-05 | $1.91M 10-Q · filed 2021-11-05 | $2.81M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $429.00K 10-Q · filed 2021-08-09 | $1.40M 10-Q · filed 2021-08-09 | $2.29M derived: sum of 3 quarters · filed 2022-02-28 | $3.27M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $967.00K 10-Q · filed 2021-05-10 | $1.86M derived: sum of 2 quarters · filed 2022-02-28 | $2.84M derived: sum of 3 quarters · filed 2022-02-28 | $3.78M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $892.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.87M derived: sum of 2 quarters · filed 2022-02-28 | $2.81M derived: sum of 3 quarters · filed 2022-02-28 | $3.41M 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $979.00K 10-Q · filed 2020-11-06 | $1.92M derived: sum of 2 quarters · filed 2020-11-06 | $2.52M 10-Q · filed 2020-11-06 | $2.98M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $941.00K 10-Q · filed 2020-08-05 | $1.00M 10-Q · filed 2019-08-08 | $1.54M 10-Q · filed 2020-08-05 | $1.60M 10-Q · filed 2019-08-08 | $2.00M derived: sum of 3 quarters · filed 2021-03-01 | $2.42M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $601.00K 10-Q · filed 2020-05-08 | $1.05M derived: sum of 2 quarters · filed 2021-03-01 | $1.48M derived: sum of 3 quarters · filed 2021-03-01 | $1.94M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $874.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.34M derived: sum of 3 quarters · filed 2021-03-01 | $1.69M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $420.00K 10-Q · filed 2019-11-08 | $888.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.24M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $468.00K 10-Q · filed 2019-08-08 | $815.00K 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | $288.00K 10-Q · filed 2019-05-09 | |||||
| 2017-12-31 | $2.00K 10-K · filed 2019-03-08 | |||||
| 2016-12-31 | $1.00K 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |